PARADIGM BIOCAPITAL ADVISORS LP United Therapeutics Corporation Transaction History

PARADIGM BIOCAPITAL ADVISORS LP portfolio value:

$29.43M
portfolio value

PARADIGM BIOCAPITAL ADVISORS LP quarter portfolio value change:

-11.14%
quarter

United Therapeutics Corporation 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -13.80% -22.50K shares -8.99M $209.38 140.56K
Q2 2022 share Increase +115.60% 87.43K shares 24.85M $235.64 163.06K
Q1 2022 share Increase 0.00% 75.63K shares 13.57M $179.41 75.63K